| Q37093827 | 13C-sialic acid labeling of glycans on glycoproteins using ST6Gal-I. |
| Q24305321 | A novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4 |
| Q73270989 | A novel subset of murine B cells that expresses unmasked forms of CD22 is enriched in the bone marrow: implications for B-cell homing to the bone marrow |
| Q26827579 | A perspective on the structure and receptor binding properties of immunoglobulin G Fc |
| Q44176615 | A solid-phase assay for the activity of CMPNeuAc:Gal β1-4GlcNAc-R α-2,6-sialyltransferase |
| Q50755716 | A soluble form of Sda-beta 1,4-N-acetylgalactosaminyltransferase is released by differentiated human colon carcinoma CaCo-2 cells. |
| Q33694538 | Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation |
| Q35848710 | Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I |
| Q35671120 | Alzheimer's beta-secretase cleaves a glycosyltransferase as a physiological substrate |
| Q33949840 | Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase |
| Q24598282 | An investigation of the role of transmembrane domains in Golgi protein retention |
| Q24322919 | Analysis of the substrate binding sites of human galactosyltransferase by protein engineering |
| Q83230248 | B cells suppress medullary granulopoiesis by an extracellular glycosylation-dependent mechanism |
| Q37065114 | B-cell-independent sialylation of IgG. |
| Q71470654 | Biosynthesis in vitro of neolactotetraosylceramide by a galactosyltransferase from mouse T-lymphoma: purification and kinetic studies; synthesis of neolacto and polylactosamine core |
| Q42583191 | Branch-specific sialylation of IgG-Fc glycans by ST6Gal-I. |
| Q28260435 | CD22: an inhibitory enigma |
| Q72091225 | CDw75 Antigen Expression in Breast Lesions |
| Q37434568 | CMP substitutions preferentially inhibit polysialic acid synthesis |
| Q78757823 | Clinicopathologic evaluation of CDw75 antigen expression in colorectal adenocarcinomas |
| Q24563854 | Cloning and analysis of the Saccharomyces cerevisiae MNN9 and MNN1 genes required for complex glycosylation of secreted proteins |
| Q36812392 | Cloning and expression of a porcine UDP-GalNAc: polypeptide N-acetylgalactosaminyl transferase |
| Q24633703 | Complete cDNA sequence encoding human beta-galactoside alpha-2,6-sialyltransferase |
| Q33269110 | Complete primary structure of porcine tenascin. Detection of tenascin transcripts in adult submaxillary glands |
| Q33269616 | Construction and characterization of new piggyBac vectors for constitutive or inducible expression of heterologous gene pairs and the identification of a previously unrecognized activator sequence in piggyBac. |
| Q72459645 | Different sialyltransferase activities in human colorectal carcinoma cells from surgical specimens detected by specific glycoprotein and glycolipid acceptors |
| Q92282635 | Direct fluorescent glycan labeling with recombinant sialyltransferases |
| Q43993993 | Direct interference with rhamnogalacturonan I biosynthesis in Golgi vesicles |
| Q30873680 | Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. |
| Q34785036 | Engineering β1,4-galactosyltransferase I to reduce secretion and enhance N-glycan elongation in insect cells |
| Q67727848 | Enhanced CMP-NeuAc:Galβ1, 4GlcNAc-R α2, 6 sialyltransferase activity of human colon cancer xenografts in athymic nude mice and of xenograft-derived cell lines |
| Q27680447 | Enzymatic Basis for N-Glycan Sialylation: STRUCTURE OF RAT 2,6-SIALYLTRANSFERASE (ST6GAL1) REVEALS CONSERVED AND UNIQUE FEATURES FOR GLYCAN SIALYLATION |
| Q39290505 | Epigenetic Bases of Aberrant Glycosylation in Cancer |
| Q39993642 | Evidence for a sialic acid salvaging pathway in lepidopteran insect cells |
| Q90222396 | Exploration of the Sialic Acid World |
| Q24564218 | Expression cloning of a CMP-NeuAc:NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer alpha 2,8-sialyltransferase (GD3 synthase) from human melanoma cells |
| Q34293809 | Expression of bovine beta-1,4-galactosyltransferase cDNA in COS-7 cells |
| Q53398450 | Expression of the CDw75 (beta-galactoside alpha 2,6-sialyltransferase) antigen on normal blood cells and in B-cell chronic lymphocytic leukaemia |
| Q107349299 | Fluorescent Glycan Fingerprinting of SARS2 Spike Proteins |
| Q47070983 | Functional Characterization of Drosophila Sialyltransferase |
| Q36290900 | Functional aspects of glycoprotein N-linked oligosaccharide processing by human tumours |
| Q35131855 | Gene silencing of β-galactosamide α-2,6-sialyltransferase 1 inhibits human influenza virus infection of airway epithelial cells |
| Q46375292 | Genetic engineering of CHO cells producing human interferon-gamma by transfection of sialyltransferases |
| Q33804543 | Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells |
| Q41240945 | Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ. |
| Q37760983 | Glycosylation in intestinal epithelium |
| Q42608228 | High-quality production of human α-2,6-sialyltransferase in Pichia pastoris requires control over N-terminal truncations by host-inherent protease activities |
| Q44590822 | Human-specific Regulation of α2–6-linked Sialic Acids |
| Q36368171 | Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells |
| Q35579621 | Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells |
| Q38288653 | Identification of the gonococcal glmU gene encoding the enzyme N-acetylglucosamine 1-phosphate uridyltransferase involved in the synthesis of UDP-GlcNAc |
| Q88445153 | IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids |
| Q36475650 | Immune regulation by the ST6Gal sialyltransferase |
| Q36815622 | Improved glycosylation of a foreign protein by Tn-5B1-4 cells engineered to express mammalian glycosyltransferases. |
| Q31118826 | Involvement of proteases in glycosyltransferase secretion: Alzheimer's beta-secretase-dependent cleavage and a following processing by an aminopeptidase |
| Q34314796 | Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl- 1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer |
| Q34335605 | Isolation of a matrix that binds medial Golgi enzymes |
| Q34289604 | Isolation of a rat liver Golgi mannosidase II clone by mixed oligonucleotide-primed amplification of cDNA. |
| Q24644108 | Isolation, characterization, and expression of cDNAs encoding murine alpha-mannosidase II, a Golgi enzyme that controls conversion of high mannose to complex N-glycans |
| Q46155748 | Large-scale expression of recombinant sialyltransferases and comparison of their kinetic properties with native enzymes |
| Q48052178 | Localization of beta-galactoside alpha2,6-sialyltransferase gene on pig chromosome 13q4.1. |
| Q40990270 | Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels |
| Q33318026 | Molecular cloning and expression of cDNA encoding the enzyme that controls conversion of high-mannose to hybrid and complex N-glycans: UDP-N-acetylglucosamine: alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I |
| Q24336308 | Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion |
| Q24321389 | Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen |
| Q37464201 | Nuclear magnetic resonance structural characterization of substrates bound to the alpha-2,6-sialyltransferase, ST6Gal-I. |
| Q27938727 | OCH1 encodes a novel membrane bound mannosyltransferase: outer chain elongation of asparagine-linked oligosaccharides |
| Q35796018 | Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression |
| Q39663097 | Overexpression of amyloid beta precursor protein enhances expression and secretion of ST6Gal1 in C2C12 myogenic cell line |
| Q36217283 | Peptide-specific transfer of N-acetylgalactosamine to O-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4 |
| Q35909612 | Polyoma and hamster papovavirus large T antigen-mediated replication of expression shuttle vectors in Chinese hamster ovary cells |
| Q34294088 | Predicting the orientation of eukaryotic membrane-spanning proteins |
| Q41153052 | Protein glycosylation in the endoplasmic reticulum and the Golgi apparatus and cell type-specificity of cell surface glycoconjugate expression: analysis by the protein A-gold and lectin-gold techniques |
| Q28114903 | Purification and cDNA Cloning of a Human UDP-N-acetyl-α- D-galactosamine:polypeptide N-Acetylgalactosaminyltransferase |
| Q34404844 | Regulation of CD45 engagement by the B-cell receptor CD22. |
| Q41057192 | Secretion of alpha1,3-galactosyltransferase by cultured cells and presence of enzyme in animal sera |
| Q67780963 | Secretion of chondroitin 6-sulfotransferase and chondroitin 4-sulfotransferase from cultured chick embryo chondrocytes |
| Q41083198 | Sequences within and adjacent to the transmembrane segment of alpha-2,6-sialyltransferase specify Golgi retention |
| Q34807554 | Shedding of glycan-modifying enzymes by signal peptide peptidase-like 3 (SPPL3) regulates cellular N-glycosylation |
| Q39038778 | Sialylation of N-glycans: mechanism, cellular compartmentalization and function. |
| Q35160084 | Sialyltransferases in cancer |
| Q38446053 | Significance of β-Galactoside α2,6 Sialyltranferase 1 in Cancers. |
| Q37670596 | Spin-labeled analogs of CMP-NeuAc as NMR probes of the alpha-2,6-sialyltransferase ST6Gal I. |
| Q38315869 | Studies on the effect of mevinolin (lovastatin) and mevastatin (compactin) on the fusion of L6 myoblasts |
| Q72033816 | Synthesis of benzyl O-(3-O-methyl-β-d-galactopyranosyl)-(1 → 3)-2-acetamido-2-deoxy-α-d-galactopyranoside and benzyl O-(β-d-galactopyranosyl)-(1 → 3)-2-acetamido-2-deoxy-6-O-methyl-α-d-galactopyranoside as specific acceptors for sialyltransferases |
| Q33804560 | Synthesis of oligosaccharides by bacterial enzymes |
| Q35574792 | Synthesis of sialoglycopolypeptide for potentially blocking influenza virus infection using a rat alpha2,6-sialyltransferase expressed in BmNPV bacmid-injected silkworm larvae |
| Q37568588 | Systems-based candidate genes for human response to influenza infection |
| Q48566892 | Targeting of active sialyltransferase to the plant Golgi apparatus |
| Q40493888 | Targeting of proteins to the Golgi apparatus |
| Q34974092 | Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell |
| Q36531267 | The 17-residue transmembrane domain of beta-galactoside alpha 2,6-sialyltransferase is sufficient for Golgi retention |
| Q24682809 | The B cell antigen CD75 is a cell surface sialytransferase |
| Q33782199 | The E1 glycoprotein of an avian coronavirus is targeted to the cis Golgi complex |
| Q24643944 | The HB-6, CDw75, and CD76 differentiation antigens are unique cell-surface carbohydrate determinants generated by the beta-galactoside alpha 2,6-sialyltransferase |
| Q37987919 | The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer's Disease and Beyond |
| Q55480200 | The expression of CMP-NeuAc: Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase [EC 2.4.99.1] and glycoproteins bearing alpha 2,6-linked sialic acids in human brain tumours. |
| Q35934419 | The membrane spanning domain of beta-1,4-galactosyltransferase specifies trans Golgi localization |
| Q64053597 | The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia |
| Q41995009 | The role of a cathepsin D-like activity in the release of Gal beta 1-4GlcNAc alpha 2-6-sialyltransferase from rat liver Golgi membranes during the acute-phase response |
| Q74552056 | The role of glycoproteins in neural development function, and disease |
| Q34292917 | The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role |
| Q34329454 | The stem region of the sulfotransferase GlcNAc6ST-1 is a determinant of substrate specificity |
| Q39797061 | Transcriptional regulation of the human ST6GAL2 gene in cerebral cortex and neuronal cells |
| Q36127847 | Transcriptome response to heat stress in a chicken hepatocellular carcinoma cell line |
| Q35063963 | Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G |
| Q24678675 | cDNA cloning reveals the molecular structure of a sperm surface protein, PH-20, involved in sperm-egg adhesion and the wide distribution of its gene among mammals |
| Q28631479 | gp25L/emp24/p24 protein family members of the cis-Golgi network bind both COP I and II coatomer |
| Q67848553 | n-butyrate reduces the expression of beta-galactoside alpha 2,6-sialyltransferase in Hep G2 cells |